CarpeDiem IAS • CarpeDiem IAS • CarpeDiem IAS •

Indian scientists develop affordable dipstick test for AMR surveillance

05 Feb 2026 GS 3 Science & Technology
Indian scientists develop affordable dipstick test for AMR surveillance Click to view full image

Context

  • Indian scientists have developed a low-cost, rapid dipstick assay to detect antimicrobial resistance (AMR) genes in sewage.

  • Developed by researchers from the Translational Health Science and Technology Institute (THSTI) Faridabad.

What is antimicrobial resistance (AMR)?

  • AMR occurs when microorganisms (bacteria, viruses, fungi, parasites) evolve mechanisms to withstand antimicrobial drugs.

  • Leads to:

    • Treatment failure

    • Longer illness duration

    • Higher healthcare costs

    • Increased mortality

  • India is considered a global hotspot for AMR due to:

    • High antibiotic consumption

    • Inadequate wastewater treatment

    • Pharmaceutical effluents

    • Over-the-counter antibiotic use

Why sewage-based AMR surveillance is important

  • Urban sewage acts as a reservoir of AMR genes.

  • Sewage provides a population-level snapshot of:

    • Antibiotic usage

    • Resistant microbes

  • Captures signals from:

    • Communities

    • Hospitals

    • Animal farms

    • Pharmaceutical industries

  • Considered:

    • Ethically acceptable

    • Economically feasible

  • Acts as an early warning system for emerging resistance.

About the dipstick assay

Basic principle

  • Detects AMR genes, not live pathogens.

  • Workflow:

    1. Collection of sewage samples

    2. Isolation of genetic material

    3. Amplification of resistance genes (using PCR)

    4. Application to dipstick with detection reagent

    5. Visible coloured bands appear if target genes are present

Results can be read with the naked eye.

Key features of the dipstick test

  • Cost-effective:

    • Unit cost: ₹400–550

    • Much cheaper than shotgun sequencing (>₹9,000 per sample)

  • Rapid:

    • Results within ~2 hours

  • Multiplex capability:

    • Each dipstick can detect 16 resistance genes simultaneously

  • Scalable and adaptable:

    • New resistance genes can be incorporated within 3 days

  • Low-resource suitability:

    • Can be deployed in minimal laboratory settings

    • Suitable for low- and middle-income countries

Comparison with existing techniques

Shotgun sequencing

  • Pros:

    • Comprehensive profiling of resistance genes

  • Cons:

    • Expensive

    • Infrastructure-intensive

    • Not suitable for routine large-scale surveillance

Dipstick assay

  • Pros:

    • Cheap

    • Fast

    • Suitable for mass surveillance

  • Cons:

    • Provides screening-level information, not definitive diagnosis

Interpretation caveat

  • Detection of a gene does not confirm disease.

  • Resistance genes indicate potential risk, not presence of viable pathogens.

  • AMR expression depends on:

    • Gene combinations

    • Environmental and biological context

  • Hence, dipstick results should guide further targeted investigations, not standalone conclusions.

Prelims Practice MCQs

Q. With reference to the recently developed dipstick test to detect antimicrobial resistance (AMR) in sewage, consider the following statements:

  1. The test detects antibiotic-resistant pathogens by culturing them in the laboratory.

  2. It provides a visual readout that can be interpreted with the naked eye.

  3. It works by detecting resistance genes present in sewage samples.

Which of the statements given above is/are correct?

A. 2 and 3 only
B. 1 and 2 only
C. 3 only
D. 1, 2 and 3

Correct answer: A

Explanation:

  • Statement 1 is incorrect: the assay does not culture pathogens; it detects resistance genes.

  • Statement 2 is correct: visible coloured bands appear on the dipstick.

  • Statement 3 is correct: the test identifies AMR genes in sewage samples.

Q. The primary institutional affiliation of the Indian scientists who developed the affordable dipstick assay for AMR detection is:

A. Indian Council of Medical Research
B. Translational Health Science and Technology Institute
C. National Institute of Virology
D. Council of Scientific and Industrial Research

Correct answer: B

Explanation:

  • The assay was developed by scientists from the Translational Health Science and Technology Institute (THSTI).



← Back to list